| Date Filed | Type | Description |
| 10/04/2023 |
SC 13D/A
| Morningside Venture Investments Ltd reports a 3.4% stake in Amylyx Pharmaceuticals, Inc. |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/17/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/07/2023 |
SC 13D/A
| Morningside Venture Investments Ltd reports a 11.2% stake in GreenLight Biosciences Holdings, PBC |
| 04/03/2023 |
SC 13D/A
| Morningside Venture Investments Ltd reports a 12.9% stake in Amylyx Pharmaceuticals, Inc. |
| 03/31/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 29,048 shares
@ $30.45, valued at
$884.5k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 34,641 shares
@ $31.69, valued at
$1.1M
Sold 28,807 shares
@ $32.17, valued at
$926.7k
|
|
| 03/17/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 9,122 shares
@ $32.55, valued at
$296.9k
|
|
| 03/16/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 70,714 shares
@ $34.54, valued at
$2.4M
Sold 108,934 shares
@ $33.12, valued at
$3.6M
Sold 41,066 shares
@ $33.68, valued at
$1.4M
|
|
| 03/06/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 50,000 shares
@ $33.75, valued at
$1.7M
|
|
| 02/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 39,916 shares
@ $35.91, valued at
$1.4M
Sold 10,084 shares
@ $36.34, valued at
$366.5k
Sold 48,889 shares
@ $35.55, valued at
$1.7M
Sold 1,111 shares
@ $36.24, valued at
$40.3k
|
|
| 02/23/2023 |
SC 13D/A
| Morningside Venture Investments Ltd reports a 30.2% stake in LumiraDx Limited |
| 02/14/2023 |
SC 13D
| Morningside Venture Investments Ltd reports a 30.2% stake in LumiraDx Limited |
| 02/07/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 25,000 shares
@ $7.146, valued at
$178.7k
Sold 40,000 shares
@ $6.883, valued at
$275.3k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 50,000 shares
@ $6.85, valued at
$342.5k
|
|
| 01/25/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 80,000 shares
@ $6.81, valued at
$544.8k
Sold 80,000 shares
@ $6.98, valued at
$558.4k
|
|
| 01/19/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 6,114 shares
@ $6.79, valued at
$41.5k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2023 |
5
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 5 on Kezar Life Sciences, Inc. |
| 01/11/2023 |
5
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 5 on Amylyx Pharmaceuticals, Inc. |
| 01/09/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 12,162 shares
@ $6.97, valued at
$84.8k
Sold 3,000 shares
@ $6.89, valued at
$20.7k
|
|
| 01/05/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 25,000 shares
@ $7.1, valued at
$177.5k
Sold 500 shares
@ $7.1, valued at
$3.6k
Sold 30,000 shares
@ $7.17, valued at
$215.1k
|
|
| 12/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/05/2022 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 28,700 shares
@ $8.779, valued at
$252k
Sold 3,612 shares
@ $8.8199, valued at
$31.9k
|
|
| 09/30/2022 |
SC 13D/A
| Morningside Venture Investments Ltd reports a 15.9% stake in Amylyx Pharmaceuticals, Inc. |
| 08/15/2022 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on GreenLight Biosciences Holdings, PBC|
Txns:
| Bought 3,061,224 shares
@ $3.92, valued at
$12M
|
|
|